Teva Pharmaceutical Industries Limited American Depositary Shares

TEVA 
(NYSE) 
 
$ 8,110 <%= Resources.Global.txtDown %>
Opdateret 17-07-2019
Ændring % -1,10% Fald i aktiekurs
Ændring -0,09 Fald i aktiekurs
Volume 5.401.296
Høj $ 8,150
Lav $ 7,810
Åben $ 8,150
ISIN
Seneste luk $ 8,200
# af aktier 920,05M
Markedsværdi 7.461,56M USD
I dag

Market closed
Teva Pharmaceutical Industries
Markedet er lukket, åbner klokken 15:30
 
Kursudvikling Seneste 1 uge 1 måned 3 mdr 6 mdr 1 år
 
  8,11 -9,6% Fald i aktiekurs -3,0% Fald i aktiekurs -43,5% Fald i aktiekurs -56,9% Fald i aktiekurs -65,5% Fald i aktiekurs
Powered by TradingView

Nyheder om Teva Pharmaceutical Industries

  • Dansk
  • Engelsk
  • Fondsbørsmeddelelser
17 jul
 
16 jul
 
16 jul
 
16 jul
 
13 jul
 
12 jul
 
12 jul
 
11 jul
 
11 jul
 
09 jul
 

Firmaprofil

Headquartered in Israel, Teva Pharmaceutical is the largest generic drug manufacturer in the world with more than 60 manufacturing and R&D facilities. The company was formed in 1901 and has a portfolio of more than 3,500 medicines--roughly one out of nine generic prescriptions in the U.S. is filled with a Teva product. The company also develops branded pharmaceuticals in the central nervous system, oncology, and respiratory categories. Teva's generic drug sales represent about half of total revenue, with branded drug and distribution revenue making up the balance. Teva is an aggressive filer to bring generic drugs to market when brand patents expire and has the most generic products pending FDA approval.

Copyright Berlingske Media 2019  Handelsbetingelser  |  Cookiedeklaration  |  Cookie- og Privatlivspolitik  |  Ophavsret og vilkår
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
18. juli 2019 02:33:46
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20190703.1 - EUROWEB6 - 2019-07-18 02:33:46 - 2019-07-18 02:33:46 - 1 - Website: OKAY